VYNE Therapeutics
VYNE
VYNE
32 hedge funds and large institutions have $16.1M invested in VYNE Therapeutics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 3 closing their positions.
Holders
32
Holders Change
–
Holders Change %
0%
% of All Funds
0.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
3
Increased
12
Reduced
9
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $3.54K | 1,799 | -69 | -4% |
|
|
MLA
27
MB, Levis & Associates
Center Valley,
Pennsylvania
| $2.05K | 1,041 | – | – |
|
|
CA
28
Centerpoint Advisors
Needham,
Massachusetts
| $1K | 350 | +350 | New |
|
29
Russell Investments Group
London,
United Kingdom
| $368 | 187 | – | – |
|
30
JPMorgan Chase & Co
New York
| $347 | 176 | +7 | +4% |
|
31
Wells Fargo
San Francisco,
California
| $128 | 65 | -109 | -63% |
|
|
ATPW
32
Ashton Thomas Private Wealth
Scottsdale,
Arizona
| $37 | 19 | +19 | New |
|
|
VF
33
Virtu Financial
New York
| – | – | -16,199 | Closed |
|
34
Millennium Management
New York
| – | – | -10,990 | Closed |
|
|
CPG
35
Cornerstone Planning Group
Fairfield,
New Jersey
| – | – | -2 | Closed |
|
|
CFGS
36
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|